Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Diabetes and Vascular Disease Research
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Vaughan, T. B.
Right arrow Articles by Moreland, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vaughan, T. B.
Right arrow Articles by Moreland, E.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Vascular disease in paediatric type 2 diabetes: the state of the art

T. Brooks Vaughan

Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, The Kirklin Clinic, TKC 4th floor, 2000 6th Avenue South, Birmingham, AL 35233-0271, US.

Fernando Ovalle

Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, The Kirklin Clinic, TKC 4th floor, 2000 6th Avenue South, Birmingham, AL 35233-0271, US.

Elaine Moreland

UAB Department of Pediatrics/Division of Pediatric Endocrinology CPP 230, 1600 7th Ave S, Birmingham, AL 35233-1711, US.

Type 2 diabetes is an emerging problem in the paediatric population. Paediatricians and paediatric endocrinologists are struggling with how to best assess, predict and treat cardiovascular risk factors in these patients. There is a notable lack of consensus in how to proceed, even among experts in the field. There are very limited data from quality trials in established paediatric type 2 diabetes. We address the available information regarding traditional and non-traditional indices of cardiovascular risk, including examination findings, biochemical markers and non-invasive imaging modalities. We discuss the utility and pitfalls of applying knowledge gained in adult medicine to the paediatric population. Potential treatment strategies are reviewed, including the currently available pharmaceutical options, with the acknowledgement that there are few drugs formally approved in the paediatric population.

Key Words: cardiovascular • paediatric • risk • treatment • type 2 diabetes

Diabetes and Vascular Disease Research, Vol. 4, No. 4, 297-304 (2007)
DOI: 10.3132/dvdr.2007.056
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?